Galderma Group N Cash Flow-to-Debt Ratio
Galderma Group N cash flow-to-debt ratio. Galderma Group N (GALD) has a Cash Flow-to-Debt Ratio of 0.09x as of June 2025, meaning its operating cash flow of CHF475.06 Million could theoretically repay 0% of its total liabilities (CHF5.15 Billion) in one year. Check GALD cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Galderma Group N (2021–2024)
Cash flow-to-debt ratio of Galderma Group N from 2021 to 2024. Historical debt coverage capacity for Galderma Group N across 4 annual periods. Check GALD cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Galderma Group N Cash Flow-to-Debt Ratio by Year (2021–2024)
Galderma Group N cash flow-to-debt ratio by year from 2021 to 2024. Year-by-year debt coverage analysis for Galderma Group N. For the full cash flow conversion analysis, see Galderma Group N cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (CHF) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.09x | CHF429.77 Million | CHF4.83 Billion | ▲ +257.8% |
| 2023 | 0.02x | CHF148.64 Million | CHF5.97 Billion | ▲ +72.1% |
| 2022 | 0.01x | CHF106.30 Million | CHF7.35 Billion | ▼ -40.9% |
| 2021 | 0.02x | CHF178.92 Million | CHF7.31 Billion | — |